| Drug Name |
Prednisolone acetate |
| Drug ID |
BADD_D01832 |
| Description |
Prednisolone acetate is a [prednisolone] molecule bound to an acetate functional group by an ester bond.[L9449]
Prednisolone acetate was granted FDA approval in 1955.[L9449] |
| Indications and Usage |
For the treatment of primary or secondary adrenocortical insufficiency, such as congenital adrenal hyperplasia, thyroiditis. Also used to treat psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, bursitis, acute gouty arthritis and epicondylitis. Also indicated for treatment of systemic lupus erythematosus, pemphigus and acute rhematic carditis. Can be used in the treatment of leukemias, lymphomas, thrombocytopenia purpura and autoimmune hemolytic anemia. Can be used to treat celiac disease, insulin resistance, ulcerative colitis and liver disorders. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
A07EA01; C05AA04; D07AA03; D07XA02; H02AB06; R01AD02; S01BA04; S01CB02; S02BA03; S03BA02 |
| DrugBank ID |
DB15566
|
| KEGG ID |
D00980
|
| MeSH ID |
C009935
|
| PubChem ID |
5834
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
62991-1692; 82298-108; 22552-0044; 52128-150; 46439-8761; 11980-180; 11980-174; 50396-7014; 64958-0048; 50090-0561; 38779-0152; 51552-0027; 61314-637; 60722-3006; 60722-2005; 76420-204; 49452-5990; 50090-5275; 72189-055; 68071-2222; 82298-107; 60758-119; 51672-1338; 50090-1912; 50090-0559 |
| Synonyms |
prednisolone acetate | prednisolone 21-acetate | pred forte | Scherisolone-Kristall suspension |
